Search
for
Sort by
Research 271–300 of 1000+
- The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Redefining hormone resistance in prostate cancer
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Serum irisin: A prognostic marker for severe acne vulgaris
- Evaluating the hormonal and biochemical markers in womens with polycystic ovarian syndrome PCOS in Missan Province
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice
- FEMALE BREAST CANCER PROTECTION USING PHYTOESTROGEN LIGNANS FROM FLAXSEED
- The study of the range and availability of Vitamin D 3 preparations in the pharmaceutical market of Ukraine
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Dilation of Multiple Eccrine Ducts as a Highly Specific Marker for Cicatricial Alopecia
- Androgen receptor gene polymorphism and biological age markers in men
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women: a randomized controlled trial with exploratory skin outcomes
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Five-alpha-reductase Inhibitors for prostate cancer prevention.